Advertisement

Topics

Companies Related to "BioStar Pharmaceuticals Pharmaceuticals Healthcare Deals Alliances Profile Report" [Most Relevant Company Matches] - Page: 20 RSS

17:09 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "BioStar Pharmaceuticals Pharmaceuticals Healthcare Deals Alliances Profile Report" found in our extensive corporate database of over 50,000 company records.

Showing "BioStar Pharmaceuticals Pharmaceuticals Healthcare Deals Alliances Profile Report" Companies 476–500 of 7,300+

Relevant

izun Pharmaceuticals

Izun Pharmaceuticals Ltd. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments. The Company's core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components. The novel therapies co...


TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...

Ceragenix Pharmaceuticals, Inc.

Ceragenix Pharmaceuticals, Inc. is a medical device company focused on infectious disease and dermatology. The Company has two base technology platforms; Ceragenins™ or (“CSAs”) for treatment of infectious disease and Barrier Repair for the treatment of dermatological disorders including atopic dermatitis, neonatal skin disorders and others. ...


Tonix Pharmaceuticals Holding Corp.

TONIX Pharmaceuticals is developing new therapies for challenging disorders of the central nervous system. The Company targets conditions characterized by significant unmet medical need, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. TONIX reformulates known pharmaceutical agents to design drugs with opt...

Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc. is a leading developer of improved treatments for diseases that affect mucosal tissues. Using its proprietary mucus penetrating particle (MPP) technology platform, Kala is able to formulate active pharmaceutical ingredients so they are able to pass through human mucus secretions, in diverse organs, including the respiratory tract...

Bio Balance, Inc.

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals. Bio Balance is devoted to a biophysical description of the initial receptor response. This should lead to improved pharmaceuticals and be an attr...

Zeta Pharmaceuticals Inc.

For those of you who know us as Zetapharm, the name of our company has been changed to Zeta Pharmaceuticals Inc. This reflects our acquiring the assets of Zetapharm from Hauser Inc. in late March 2003. We are once again a wholly-owned subsidiary of the Zuellig Group N.A. and there is no longer any affiliation with Hauser Inc. As before, our activities include: Sourcing, importation and distributi...

HANFORD PHARMACEUTICALS

In hospitals across America, physicians manage the risks of infection with a wide range of antibiotics at their disposal.Many of these antimicrobials remain patent-protected and available only from their innovators. But a greater number of still-valuable agents are off-patent or licensed for supply from additional producers.Hanford Pharmaceuticals, founded in 1846 in Upstate New York and still pri...

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Corporation is the U.S. member of the Boehringer Ingelheim worldwide group of companies dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products. It is the principal U.S. licensee of Boehringer Ingelheim GmbH, an international chemical and pharmaceutical firm that develops, produces and sells pharmaceuticals, veteri...

Specialty Pharmacy Times®

Specialty Pharmacy Times® is a leading industry journal serving the business and practice of specialty pharmaceuticals and therapy. Published by Pharmacy Times, the journal focuses on key areas surrounding specialty pharmaceuticals and the enhanced practice needs of pharmacists in this arena. The journal is available at SpecialtyPharmacyTimes.com. ...

The Rehabilitation Institute of Chicago

The Rehabilitation Institute of Chicago (RIC) is making a difference in the world for people with disabilities. RIC provides world-class care to patients from around the globe for a range of conditions from acute brain and spinal cord injury to chronic arthritis, pain and sports injuries. RIC, founded in 1954, has been designated the "#1 Rehabilitation Hospital in America" by U.S. News & World Rep...

APP Pharmaceuticals, Inc.

APP Pharmaceuticals, Inc. is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care faciliti...

MAP Pharmaceuticals, Inc.

JHP Pharmaceuticals, LLC

N30 Pharmaceuticals

PD-Rx Pharmaceuticals, Inc.

HS Pharmaceuticals, LLC

DFB Pharmaceuticals, Inc.

P&G Pharmaceuticals, Inc.

PBM Pharmaceuticals, Inc.

ECR Pharmaceuticals Co., Inc.

TOPICA Pharmaceuticals, Inc.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company is focused on conducting the Phase 2b/3 SOLUTION Study, a robust dose finding and proof of efficacy trial with luliconazole in onychomycosis with...

Life Time Pharmaceuticals Incorporated

LifeTime™ Pharmaceuticals, a private clinical-stage pharmaceutical company, focuses on the development of drugs that are safe enough for long-term, chronic administration. Compounds currently under development seek to eliminate and prevent recurrence of potentially fatal cancers and infectious syndromes. Human clinical trial results presented at several scientific meetings (see below) have shown...

Tokai Pharmaceuticals

Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The company’s lead drug candidate, TOK-001, is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one oncotherapeutic....

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs for serious infections such as drug resistance and gram-negative infections. The company has developed an emerging pipeline of p...


More From BioPortfolio on "BioStar Pharmaceuticals Pharmaceuticals Healthcare Deals Alliances Profile Report"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks